BIO€QUITY Europe 2024

San Sebastian, Spain

12th May, 2024

Meet Axoltis Pharma’s CEO Yann GODFRIN, Ph.D., at Bio Equity Europe in San Sebastian, Spain from May 12th to 14th 2024 to know more about NX210c, our very promizing drug candidate authorized to enter in Phase II trial in Amyotrophic Lateral Sclerosis